Katharina Rox

4.6k total citations · 1 hit paper
36 papers, 2.8k citations indexed

About

Katharina Rox is a scholar working on Molecular Biology, Infectious Diseases and Molecular Medicine. According to data from OpenAlex, Katharina Rox has authored 36 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 12 papers in Infectious Diseases and 11 papers in Molecular Medicine. Recurrent topics in Katharina Rox's work include Antibiotic Resistance in Bacteria (11 papers), Antibiotics Pharmacokinetics and Efficacy (7 papers) and Bacterial biofilms and quorum sensing (6 papers). Katharina Rox is often cited by papers focused on Antibiotic Resistance in Bacteria (11 papers), Antibiotics Pharmacokinetics and Efficacy (7 papers) and Bacterial biofilms and quorum sensing (6 papers). Katharina Rox collaborates with scholars based in Germany, France and United States. Katharina Rox's co-authors include Stephan Becker, Lucie Sauerhering, Linlin Zhang, Rolf Hilgenfeld, Xinyuanyuan Sun, Christian Drosten, Ute Curth, Daizong Lin, Mark Brönstrup and Alexander Titz and has published in prestigious journals such as Science, Journal of the American Chemical Society and Angewandte Chemie International Edition.

In The Last Decade

Katharina Rox

34 papers receiving 2.8k citations

Hit Papers

Crystal structure of SARS-CoV-2 main protease provides a ... 2020 2026 2022 2024 2020 500 1000 1.5k 2.0k

Peers

Katharina Rox
Ute Curth Germany
K. Anand Germany
Linlin Zhang Germany
Yanmei Hu United States
Katharina Rox
Citations per year, relative to Katharina Rox Katharina Rox (= 1×) peers Xinyuanyuan Sun

Countries citing papers authored by Katharina Rox

Since Specialization
Citations

This map shows the geographic impact of Katharina Rox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katharina Rox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katharina Rox more than expected).

Fields of papers citing papers by Katharina Rox

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katharina Rox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katharina Rox. The network helps show where Katharina Rox may publish in the future.

Co-authorship network of co-authors of Katharina Rox

This figure shows the co-authorship network connecting the top 25 collaborators of Katharina Rox. A scholar is included among the top collaborators of Katharina Rox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katharina Rox. Katharina Rox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Krämer, Andreas, Stefan Knapp, Catherine Dunyach‐Remy, et al.. (2025). Targeting bacterial kinases as a strategy to counteract antibiotic resistance. Communications Chemistry. 8(1). 390–390. 1 indexed citations
2.
Sheldon, Julie, Qinggong Yuan, Richard J. P. Brown, et al.. (2025). Adapted hepatitis C virus clone infects innate immunity-deficient mouse hepatocytes with minimal human HCV entry factors. JHEP Reports. 7(5). 101328–101328.
3.
Illarionov, Boris, Katharina Rox, Markus Fischer, et al.. (2024). Targeting Plasmodium falciparum IspD in the Methyl- d -erythritol Phosphate Pathway: Urea-Based Compounds with Nanomolar Potency on Target and Low-Micromolar Whole-Cell Activity. Journal of Medicinal Chemistry. 67(19). 17070–17086. 4 indexed citations
4.
Hoff, Katharina J., Yunqi Li, Jörg Haupenthal, et al.. (2024). Development of Fragment-Based Inhibitors of the Bacterial Deacetylase LpxC with Low Nanomolar Activity. Journal of Medicinal Chemistry. 67(19). 17363–17391. 2 indexed citations
5.
Tegge, Werner, Chunfa Xu, Kirsten Harmrolfs, et al.. (2024). A Targeted Click‐to‐Release Activation of the Last‐Resort Antibiotic Colistin Reduces its Renal Cell Toxicity. Angewandte Chemie International Edition. 63(47). e202408360–e202408360. 3 indexed citations
6.
Rox, Katharina, et al.. (2024). Synthetic studies on the tetrasubstituted D-ring of cystobactamids lead to potent terephthalic acid antibiotics. Communications Chemistry. 7(1). 252–252.
7.
Rox, Katharina & Eva Medina. (2024). Aerosolized delivery of ESKAPE pathogens for murine pneumonia models. Scientific Reports. 14(1). 2558–2558. 2 indexed citations
8.
Hamed, Mostafa M., Ahmed S. Abdelsamie, Katharina Rox, et al.. (2023). Towards Translation of PqsR Inverse Agonists: From In Vitro Efficacy Optimization to In Vivo Proof‐of‐Principle. Advanced Science. 10(5). e2204443–e2204443. 18 indexed citations
10.
Rox, Katharina, Rolf Jansen, Jennifer Herrmann, et al.. (2023). Pharmacokinetic and pharmacodynamic evaluation of the atypical tetracyclines chelocardin and amidochelocardin in murine infection models. Microbiology Spectrum. 12(1). e0128923–e0128923. 1 indexed citations
11.
Graspeuntner, Simon, Jennifer Herrmann, Katharina Rox, et al.. (2023). Sorangicin A Is Active against Chlamydia in Cell Culture, Explanted Fallopian Tubes, and Topical In Vivo Treatment. Antibiotics. 12(5). 795–795. 1 indexed citations
12.
Kuhaudomlarp, Sakonwan, Dirk Hauck, Émilie Gillon, et al.. (2022). Neutralizing the Impact of the Virulence Factor LecA from Pseudomonas aeruginosa on Human Cells with New Glycomimetic Inhibitors. Angewandte Chemie International Edition. 62(7). e202215535–e202215535. 27 indexed citations
13.
Rox, Katharina, Tim Becker, Andrea Schiefer, et al.. (2022). Pharmacokinetics and Pharmacodynamics (PK/PD) of Corallopyronin A against Methicillin-Resistant Staphylococcus aureus. Pharmaceutics. 15(1). 131–131. 4 indexed citations
14.
Rox, Katharina. (2022). Influence of tramadol on bacterial burden in the standard neutropenic thigh infection model. Scientific Reports. 12(1). 19606–19606. 5 indexed citations
15.
Rox, Katharina, Silke Rath, Dietmar H. Pieper, Marius Vital, & Mark Brönstrup. (2021). A simplified LC-MS/MS method for the quantification of the cardiovascular disease biomarker trimethylamine-N-oxide and its precursors. Journal of Pharmaceutical Analysis. 11(4). 523–528. 19 indexed citations
16.
Zhang, Linlin, Daizong Lin, Xinyuanyuan Sun, et al.. (2020). Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors. Science. 368(6489). 409–412. 2334 indexed citations breakdown →
17.
Mamareli, Panagiota, Friederike Kruse, Melanie Guderian, et al.. (2020). Targeting cellular fatty acid synthesis limits T helper and innate lymphoid cell function during intestinal inflammation and infection. Mucosal Immunology. 14(1). 164–176. 30 indexed citations
18.
Sommer, Roman, Katharina Rox, Stefanie Wagner, et al.. (2019). Anti-biofilm Agents against Pseudomonas aeruginosa: A Structure–Activity Relationship Study of C-Glycosidic LecB Inhibitors. Journal of Medicinal Chemistry. 62(20). 9201–9216. 59 indexed citations
19.
Rox, Katharina, Manfred Rohde, Gursharan S. Chhatwal, & Rolf Müller. (2017). Disorazoles Block Group A Streptococcal Invasion into Epithelial Cells Via Interference with the Host Factor Ezrin. Cell chemical biology. 24(2). 159–170. 12 indexed citations
20.
Rox, Katharina, Rolf Jansen, Torsten G. Loof, et al.. (2017). Linoleic and palmitoleic acid block streptokinase-mediated plasminogen activation and reduce severity of invasive group A streptococcal infection. Scientific Reports. 7(1). 11798–11798. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026